Study of appropriate CRM using preoperative MRI evaluation for cecal cancer and ascending colon cancer

Study of appropriate CRM using preoperative MRI evaluation for cecal cancer and ascending colon cancer - Study of appropriate CRM using preoperative MRI evaluation for cecal cancer and ascending colon cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048369

Enrollment

Registered

2022-07-13

Start date

2022-07-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who have undergone colonoscopy and have been diagnosed with colorectal cancer or ascending colon cancer by endoscopy and fluoroscopy or CT or MRI. 2. Patients whose preoperative T factor can be diagnosed as deeper than T2 by endoscopy or CT. 3. Patients who can undergo R0 resection (curative resection) by laparotomy or laparoscopic surgery. 4. Patients aged 18 years or older at the time of consent acquisition. 5. Patients who have received sufficient explanation in participating in this study, and who have obtained sufficient understanding and voluntary written consent of the patient.

Exclusion criteria

Exclusion criteria: 1. Patients with Stage IV with distant metastasis and peritoneal dissemination 2. Patients with double cancer 3. Patients with multiple cancers 4. Other patients who the principal investigator deems inappropriate for research

Design outcomes

Primary

Measure	Time frame
Match rate between estimated CRM and pathological CRM	—

Secondary

Measure	Time frame
Recurrence rate 3 years after surgery(peritoneal dissemination, local recurrence)	—

Countries

Japan

Contacts

Public ContactAdachi Toshiyuki

Nagasaki university Department of Surgery

t-adachi@nagasaki-u.ac.jp0958197317

Outcome results